GlassScriptPhysician profile
Terry Lee Adams
NPI 1730105610
$25,686.06
in general payments reported to CMS, 2019-2025
41 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,906 · 2020: $751 · 2021: $904 · 2022: $5,014 · 2023: $14K · 2024: $849 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,750 · Food and Beverage: $4,297 · Travel and Lodging: $4,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,750.00 |
| Food and Beverage | $4,296.78 |
| Travel and Lodging | $4,063.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,915.98 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbott Laboratories | $2,896.22 | 2020-2024 | Jeti Peripheral Catheter, Jeti, Esprit |
| Medtronic, INC. | $2,837.12 | 2021-2025 | Turbohawk, Hawkone, Endurant Iis |
| Penumbra, INC. | $2,277.12 | 2022-2025 | Indigo System, Penumbra System, Smart Coil |
| Davol INC. | $2,002.83 | 2019-2025 | Phasix Mesh |
| Cardiovascular Systems INC. | $1,085.00 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $822.64 | 2019-2025 | Lifevest |
| Silk Road Medical, INC. | $559.37 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $351.66 | 2019-2021 | |
| Inari Medical, INC. | $184.06 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| C. R. Bard, INC. & Subsidiaries | $176.80 | 2019 | |
| Conmed Corporation | $168.54 | 2023 | Airseal |
| Organogenesis INC. | $150.87 | 2021-2024 | |
| Allergan, INC. | $142.29 | 2019 | |
| Merck Sharp & Dohme LLC | $128.17 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $76.03 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $71.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $71.77 | 2021-2022 | |
| Janssen Biotech, INC. | $69.07 | 2024 | Stelara, Simponi, Tremfya |
| Neurocrine Biosciences, INC. | $65.66 | 2024 | Ingrezza |
| Ethicon US, LLC | $61.19 | 2021-2024 | Echelon Flex, Surgicel Nu-Knit, Harmonic |
| Abbvie INC. | $60.08 | 2021-2022 | |
| Lemaitre Vascular, INC. | $58.73 | 2022 | |
| Pfizer INC. | $51.92 | 2019-2024 | |
| Nevro Corp. | $48.04 | 2023 | Senza |
| Amgen INC. | $40.22 | 2019 | |
| Novo Nordisk INC | $39.63 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.12 | 2024 | Caplyta |
| Medtronic Vascular, INC. | $26.86 | 2020 | |
| Philips North America LLC | $25.63 | 2019 | |
| Radius Health, INC. | $25.23 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.49 | 2021 | |
| Tactile Systems Technology INC | $19.82 | 2020 | |
| Aimmune Therapeutics, INC. | $19.41 | 2024 | |
| Solventum Corporation | $15.72 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Neotract INC. | $15.08 | 2019 | |
| Olympus America INC. | $15.06 | 2021 | |
| Xeris Pharmaceuticals, INC. | $14.87 | 2025 | Gvoke Hypopen |
| Cordis US Corp. | $12.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.16 | 2019 | |
| Endogastric Solutions, INC | $10.30 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.